Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

Peer Review reports

Original Submission
30 Jan 2006	Submitted	Original manuscript
13 Feb 2006	Reviewed	Reviewer Report - Marino Zorzon
9 Mar 2006	Reviewed	Reviewer Report - hans-peter hartung
26 Apr 2006	Author responded	Author comments - Florian Then Bergh
Resubmission - Version 2
26 Apr 2006	Submitted	Manuscript version 2
2 May 2006	Reviewed	Reviewer Report - hans-peter hartung
10 May 2006	Reviewed	Reviewer Report - Marino Zorzon
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
23 May 2006	Editorially accepted
23 May 2006	Article published	10.1186/1471-2377-6-19

Back to article page